# The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers

**Autores:** Diego Flores-Funes, José Aguilar-Jiménez, María Martínez-Gálvez et al.
**Revista:** Cir Esp (Engl Ed) (2020)
**PMID:** 32386728 | **PMCID:** —
**DOI:** [10.1016/j.ciresp.2020.03.012](https://doi.org/10.1016/j.ciresp.2020.03.012)
**Fuente:** PubMed (abstract only — full text vía DOI/institución)

## Relevancia
Revisión sistemática en español sobre TAD y tipos de marcaje del ganglio afectado (clips metálicos, semillas de radioyodo, semillas ferromagnéticas) para re-estadificar la axila post-quimioterapia neoadyuvante en cáncer de mama. Referencia clave en la literatura hispanohablante.

## Abstract
Targeted axillary dissection (TAD) consists of a new axillary staging technique that combines sentinel lymph node biopsy (SLNB) and clipped lymph node biopsy (CLNB) in the same surgery, in order to re-stage patients with breast cancer and positive axillary lymph nodes undergoing neoadjuvant chemotherapy (NAQT). Prior to the NAQT, the affected lymph node is punctured and a solid marker is left inside echo-guided, in order to biopsy it in the subsequent surgery. There are numerous types of markers: metallic (steel, titanium or polyglycolic acid clips), radioiodine or ferromagnetic seeds, which differ in the method of location (wire, gamma-detection or magnetic probe). The aim of this study is to perform a systematic review about the current status of the TAD, as well as to explain the different techniques and types of axillary marking, based on the current available evidence.

## Acceso
Artículo no disponible en PMC. Acceder a través de [DOI](https://doi.org/10.1016/j.ciresp.2020.03.012) o suscripción institucional.

---
*Datos de PubMed. Citar: doi 10.1016/j.ciresp.2020.03.012*
